Diagnostic direction: Acute coronary syndrome

General description

High-sensitivity troponin (hs-cTn) is a sensitive early biomarker of myocardial infarction and an independent predictor of adverse outcomes in any patient with symptoms of acute coronary syndrome (ACS) and positive test results. hs-cTn has better sensitivity and can detect myocardial damage earlier than current cTn tests. Low hs-cTn concentrations can completely exclude acute myocardial infarction.

In patients with congestive heart failure, a high serum hs-cTn concentration is a useful prognostic predictor independent of either reduced LV ejection fraction or BNP levels, suggesting that elevated hs-cTn concentrations reflect the development of myocardial damage.

Indications for administration

1. Presence of symptoms indicating myocardial ischemia, including those without ECG changes.
2. Diagnosis of myocardial infarction in patients with chronic renal failure who have symptoms of myocardial ischemia (regardless of the severity of renal damage).
3. Diagnosis of myocardial damage in patients receiving chemotherapy.
4. Patients with heart failure with preserved or reduced ejection fraction to assess the risk of mortality or hospitalization. A troponin level above the 99th percentile is associated with a high probability of an unfavorable outcome.
5. All patients with signs of acute heart failure to exclude acute myocardial infarction.

Biological material: venous blood in a serum tube, or EDTA, or Li-heparin

Patient preparation: no special preparation is required (unless otherwise prescribed by a physician)

Contractor: Dobrolab

Contraindications: none

Time of execution: 24 hours

The service is provided at the subdivisions: All divisions of MM “Dobrobut”

Algorithm of service in the contact center: the contact center can make an appointment for this study